|
Name: Lormetazepam
Type: Benzodiazepine
AKA: Noctamid
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
Lormetazepam, a benzodiazepine, was developed in the 1970s and introduced as a treatment for anxiety and insomnia. It is known for its sedative and anxiolytic effects. Lormetazepam is used primarily in Europe and has been studied for its safety profile compared to other benzodiazepines, though it is subject to the same regulations due to potential for abuse.
|
|
V. Legal Information
Lormetazepam, a benzodiazepine used for anxiety and sleep disorders, is classified as a Schedule IV controlled substance in the US. Globally, it is similarly regulated to manage its use while preventing misuse and addiction.
US Federal Schedule - IV
Schedule IV drugs, substances, or chemicals are defined as drugs with a low potential for abuse and low risk of dependence. Some examples of Schedule IV drugs are: Xanax, Soma, Darvon, Darvocet, Valium, Ativan, Talwin, Ambien, Tramadol.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
Lormetazepam, a benzodiazepine, is used for treating anxiety and insomnia. As a downer, it induces significant sedation and relaxation. Short-term effects include reduced anxiety and improved sleep, while long-term use may lead to dependence and cognitive impairment. Overdose risks involve severe sedation and respiratory issues. Safe dosing typically ranges from 1-2 mg nightly. Recent research focuses on its efficacy and risks associated with long-term use.  |
|
VII. Psychological Effects
Lormetazepam, a benzodiazepine, enhances GABA-A receptor activity, providing anxiolytic and sedative effects. Immediate effects include reduced anxiety and improved sleep, with long-term use potentially leading to cognitive decline and dependence. Research explores its efficacy for anxiety and sleep disorders.
 |
|
VIII. Culture
Lormetazepam, a benzodiazepine, is used for short-term treatment of severe insomnia. Benzodiazepines have a long history of use in managing anxiety and sleep disorders, often reflecting societal attitudes towards mental health and pharmaceutical intervention. In modern culture, they are both praised for their efficacy and criticized for their potential for dependence and abuse. Lormetazepam's role in sleep health underscores broader conversations about the balance between effective treatment and the risks of long-term medication use. Media discussions often highlight personal stories of dependence, contributing to ongoing debates about mental health treatment.
 |